Evidence map›Paper›PMID 12378409›Full record

ArticleGene therapy2002

Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons.

P A Horn, J C Morris, A A Bukovsky, R G Andrews, L Naldini, P Kurre, H-P Kiem

Open access · greenAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Gene therapy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Genetic Strategies for HIV Treatment and Prevention.Molecular therapy. Nucleic acids · 2018
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. SV2 regulates neurotransmitter release via multiple mechanisms.American journal of physiology. Cell physiology · 2010
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Extracellular signal-regulated kinase (ERK) 5 is necessary and sufficient to specify cortical neuronal fate.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  14. Foamy virus vector integration sites in normal human cells.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

P A HornClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
J C Morris
A A Bukovsky
R G Andrews
L Naldini
P Kurre
H-P Kiem
Fred Hutch Cancer Center · USUniversity of Turin · ITUniversity of Washington · US

Funding

YILMA SIV VACCINIA VACCINE TRIALP51RR000166 · NCRR · UNIVERSITY OF WASHINGTON · PI HU, SHIU-LOK · 1985 to 2011
$161.1M
VECTOR CONSTRUCTIONS FOR GENE THERAPY OF SICKLE CELL DISEASEP01HL053750 · NHLBI · UNIVERSITY OF WASHINGTON · PI RUSSELL, DAVID W · 1994 to 2014
$30.4M
CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HEIMFELD, SHELLY · 1999 to 2014
$14.9M
TRANSDUCTION OF BABOON HEMATOPOIETIC STEM CELLSP50HL054881 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BERNSTEIN, IRWIN · 1995 to 2004
$11.0M
PILOT STUDY--RETROVIRUS MEDIATED TRANSFER OF HUMAN GLUCOCEREBROSIDASE GENEP30DK047754 · NIDDK · UNIVERSITY OF WASHINGTON · PI MILLER, ARTHUR DUSTY · 1994 to 2008
$8.4M
NCRR NIH HHS RR00166NHLBI NIH HHS HL53750NHLBI NIH HHS HL54881NIDDK NIH HHS DK47754NIDDK NIH HHS DK56465
6 · The paper itself

Abstract

Efficient transduction of hematopoietic stem cells is a prerequisite for successful hematopoietic stem cell gene therapy. Oncoretroviral vectors are the most widely used vectors for hematopoietic gene therapy studies. However, these vectors require cell division, and thus efficient transduction of quiescent stem cells has been difficult to achieve. Lentiviral vectors can transduce non-dividing cells and therefore may be more efficient in transducing quiescent hematopoietic stem cells. We have used a competitive repopulation assay in the baboon to compare transduction of hematopoietic repopulating cells by lentiviral and oncoretroviral vectors. Baboon CD34-enriched marrow cells were transduced in the presence or absence of multiple hematopoietic growth factors using a short, 2-day, transduction protocol. Here, we show that efficient lentiviral transduction of hematopoietic repopulating cells was only achieved when cells were transduced in the presence of multiple growth factors. Using these conditions, up to 8.6% of hematopoietic repopulating cells were genetically modified by the lentiviral vector more than 1 year after transplant. Interestingly, the number of lentivirally marked cells increased over time in three of four animals. In conclusion, these results suggest that lentiviral vectors are able to tranduce multilineage hematopoietic stem cells, and thus, may provide an alternative vector system for clinical stem cell gene therapy applications.

Indexed as

Hematopoietic Stem CellsTransduction, GeneticAnimalsAntigens, CD34Cells, CulturedGene ExpressionGenetic TherapyGreen Fluorescent ProteinsHematopoietic Cell Growth FactorsLentivirusLuminescent ProteinsModels, AnimalPapioPolymerase Chain ReactionRecombinant ProteinsRetroviridaeAntigens, CD34Green Fluorescent ProteinsHematopoietic Cell Growth FactorsLuminescent ProteinsRecombinant Proteins

Identifiers

PMID12378409
OpenAlexW2333275243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.